Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:APC.H)

Canadian Investment Regulatory Organization Trading Halt - APC.H

Canada NewsWire December 5, 2023

Advanced Proteome Therapeutics to Proceed with Its Proposed Plan of Arrangement

Newsfile March 6, 2023

IIROC Trading Resumption - APC

Canada NewsWire January 17, 2023

Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement

Newsfile January 17, 2023

IIROC Trading Halt - APC

Canada NewsWire January 17, 2023

Advanced Proteome Therapeutics (TSXV:APC) closes non-brokered private placement

John Ballem  December 28, 2022

Advanced Proteome Therapeutics Announces Closing of Non-Brokered Private Placement

Newsfile December 23, 2022

Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors

Newsfile November 21, 2022

Advanced Proteome Therapeutics (TSXV:APC) subsidiary featured in a peer-reviewed publication

Brieanna McCutcheon  August 17, 2022
View More News ››

Opinion & Analysis (TSXV:APC.H)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:APC.H)

RE:Advanced Proteome downgraded to NEX

These Jag-offs are really ruining this company, aren't  they?
qwikwit - May 21, 2023

Advanced Proteome downgraded to NEX

2023-05-15 16:26 ET - Symbol Change   In accordance with TSX Venture Exchange Policy 2.5, the company has not maintained the...
sollmg - May 16, 2023

Linceis

Are these Linceis shares going to replace our APC shares, or are these in addition to?  I see them  in my account now as well...
qwikwit - March 30, 2023

RE:LINCEIS CAP COM

Are these Linceis shares going to replace our APC shares, or are these in addition to?  I see them  in my account now as well...
qwikwit - March 29, 2023

LINCEIS CAP COM

shares are 1 for 1 or equal to whatever APC shares I held. No symbol assigned or value so far.....regardless both my accts are well...
Magnum2 - March 21, 2023

RE:Advanced Proteome distribution of Linceis shares

I noticed Linceis shares in my account today (21 Mar). Looks like came in as Linceis shares after Mondays close. Was surprised they didn&...
sollmg - March 21, 2023
View more Bullboard ››

Slam Exploration Ltd

Slam Exploration Ltd

SLAM Exploration Ltd. is a Canadian junior resource company holding a portfolio of gold and base metal projects. The Company ...
View More »